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Abstract
Although there are very effective treatment approaches for ADHD available, the clini‐
cal management has its limits and a search for new treatment modalities is useful.
rTMS found its use in neurology and is widely applied in psychiatric research and al‐
though its effect seems mild, it can be specific to some extend. The text reviews cur‐
rent knowledge on the neurobiology of ADHD symptoms with regard to a possible
rTMS treatment. The basics of the rTMS method are described. The use of rTMS is
summarized both generally in psychiatric disorders and specifically in ADHD. The
safety issues are discussed both in adults and children. The text also brings a case
study where rTMS was applied in an adult patient with ADHD.
Keywords: ADHD, rTMS, neurobiology
1. Introduction
1.1. Limits of current treatments for ADHD
Although the current treatment approaches in ADHD are highly supported by research and
are very effective, they are not suitable for all patients in need for treatment. Medications used
in clinical practice are generally well tolerated; however, they have some safety issues.
Cardiovascular effects are the most important of them. Both stimulants and atomoxetine
increase heart rate and blood pressure and for some patients it prevents their use. Treatment
with stimulants belongs to the most effective within psychiatry. Almost all guidelines
recommend stimulants as first-line treatment. However, 20–35% of children and adolescents
in clinical trials may have an inadequate response to initial stimulant treatment either due to
insufficient efficacy or non-adherence [1]. The response rate in atomoxetine is even lower, with
40% of patients without significant improvement [2]. In adults, the response rates for methyl‐
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phenidate are around 50% [3]. The long-time studies in adults with ADHD show high rates of
non-adherence to medications. Only about half of the patients remain in treatment after two
years [4]. As for the psychosocial treatment, the evidence-based efficacy remains unclear,
although psychosocial treatments can have some positive impact for children with ADHD
beyond the impact of pharmacologic treatment alone. The quality of studies aimed at psycho‐
social interventions is insufficient, although it improves continuously [5].
Therefore, although specific pharmacotherapies for ADHD exist, they are not always available
or suitable for all individuals. Moreover, as for the effect on specific symptom clusters, such
as impulsivity, inconsistent data exist with both positive and negative effect of stimulants [6].
Even more, there are other issues, such as parents‘ non-acceptance of pharmacological
treatment, that limit the benefit from pharmacological treatment. The need for novel treatment
approaches is clear. Repetitive transcranial magnetic stimulation (rTMS), one of the most
recent treatment approaches in psychiatry, allows selective neuromodulation of regions
involved in the functional neuroanatomy of individual symptomatic profiles.
1.2. Functional neuroanatomy of ADHD symptoms
Although there exist unifying theories on the nature of symptom clusters in ADHD, the
evidence on unequal expression of individual symptoms across clinical samples suggests that
at least some symptom clusters are based on distinct neurobiology. This notion is demonstrat‐
ed by a multivariate analysis of the results of testing of a large sample of ADHD subjects using
cognitive battery that focused on cognitive control, reward- and time-processing that showed
that these domains form distinct components, and that 80 % of subjects who had a deficit were
deficient on only one component [7]. Dysfunctions in these cognitive domains may manifest
in distinct symptom profiles in ADHD, i.e. inattention, impulsivity, and hyperactivity. Below,
we summarize their functional neuroanatomy to evaluate the potential targets for rTMS
treatment.
1.2.1. Impulsivity
Impulsivity is a clinically important feature that accompanies many neuropsychiatric disor‐
ders, including ADHD, and constitutes a significant risk for their development, and compli‐
cates their course and treatment. In contrast to its frequent manifestation and significant
impact, relatively little is known about its neurobiology, and, more importantly, there is no
effective specific treatment available at present, except for behavioral modification. This
situation may result from inadequate definition of impulsive behaviour with insufficient
discrimination between phenomenologically similar, but neurobiologically different, process‐
es.
Indeed, impulsivity is a heterogeneous concept which manifests in many ways, such as
personality traits, behavioral features and particular way of behavioural and cognitive task
performance. Moreover, in clinical populations, there is rather variable phenomenology of
behaviour that is generally labeled as impulsive and a considerable inconsistency of impul‐
sivity concepts in neuropsychiatric disorders exists. It is not clear if there is a single psycho‐
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logical process linked to a distinct neurobiology or if discrete patterns of impulsive behaviour
could be found with specific functional neuroanatomy in various clinical contexts.
Impulsive behaviour is the execution of an immediate urge to act, bypassing consideration of
possible means and outcomes of available alternatives. In a closer look, there may be several
sources of such behaviour. Moreover, behaviours like compulsions or hyperactivity may
resemble impulsivity on the phenomenological level while they result from different neuro‐
biological and psychological processes [8]. Contemporary neuroscience opens new possibili‐
ties for objective analysis of neurophysiological sources of behavior. Moreover, it brings new
ways of treatment that are guided by detailed knowledge of neurobiology of individual signs
and symptoms.
Impulsivity may be expressed in personality traits, cognitive and emotional processes or
behaviour control [9]. Impulsive personality traits include impulsivity proper, i.e. tendency
to act rashly without evaluation of consequences (most frequently measured using the Barrat
Impulsivity Scale); furthermore, it is reflected in the concept of sensation seeking (search of novel
intense experiences without consideration of associated risks), lack of perseverance, positive and
negative urgency (a tendency to act rashly during intense positive or negative affects) or high
reward sensitivity.
Cognitive manifestation of impulsivity includes a concept of behavioural disinhibition, i.e.
inability to suppress irrelevant or unfavourable behaviour (“stop impulsivity” – Go-No go
task, Stop signal task), and a concept of risky decision-making and reward processing with
preference of immediate, but in a long run, disadvantageous gains, and inability to postpone
reward (“wait impulsivity” – various modifications of Delayed Discounting paradigm, Iowa
Gambling task). Compulsion is a repetitive urge to act that leads to a stereotyped behavior;
impulsivity, on the other hand, is not stereotypic.
The forms of impulsivity associated with ADHD involve the inadequate control of behaviour,
poor sustained inhibition, the inability to delay a response or defer gratification, or the inability
to inhibit dominant or prepotent responses. An equal or perhaps greater problem is the delay
aversion – children and adults find waiting aversive, and therefore they act impulsively to
terminate the delay more quickly. There is a reduction of symptoms of impulsivity with age,
but adults still describe some symptoms of it. The clinical manifestations of impulsivity are
described as “acts before thinking”, “does not learn from mistakes”, “says things without
thinking” and “does not think about risks or effects of actions” [10, 11]. Impulsivity in
individuals with ADHD is associated with greater emotional and behavioral impairments in
all stages of life. The consequences of impulsivity often include poor academic and occupa‐
tional performance, problems in interpersonal relationships. Impulsivity is also associated
with an elevated risk for substance abuse, cigarette smoking, driving problems or antisocial
behaviors. [12]
1.2.1.1. Functional neuroanatomy of impulsivity
Functional neuroanatomy of symptoms is based on imaging of brain activity during execution
of a specific behavioral paradigm. Therefore, there are no studies of impulsivity, hyperactivity,
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nor any other clinical symptom. Rather, the neuroanatomy is based on associations between
a particular pattern of responses during behavioral paradigm that engage specific cognitive
processes and clinical manifestation of an illness. Impulsivity is associated with changes in
reward processing, behavioral inhibition, and, perhaps, time processing. Failures in any of
these processes can manifest as impulsivity. Although it might be difficult sometimes to
differentiate what process causes a specific pattern of behavioral responses, for the sake of
clarity the functional neuroanatomy of reward, behavioral inhibition, and time processing will
be elaborated individually. The evidence suggests that they represent distinct patterns of brain
circuit dysfunctions, and, therefore, they may form distinct phenotypes of impulsivity (i.e.
“stopping” – “inhibition-dependent” and “waiting” – “reward-dependent” impulsivity).
Test features that require inhibition of inappropriate behaviour activate right inferior frontal
gyrus, orbitofrontal gyrus, anterior cingulate, motor and premotor regions (motor cortex M1,
supplementary motor area, dorsal premotor cortex), striatum, thalamus, and nucleus subtha‐
lamicus. It seems that behavioural inhibition itself consists of several subprocesses: inhibition
of interference, response delay, and response cancellation. All of them are linked to the
activation of the right inferior frontal gyrus, supplementary motor cortex, and parietal cortex.
Inhibition of interference activates to a greater degree premotor and parietal cortex; cancella‐
tion of response represents a late phase of response inhibition and is linked with higher
activation of fronto-striatal circuits. Meta-analysis of fMRI studies revealed strong evidence
for decreased activation of the right inferior frontal gyrus, right supplementary motor area
(BA6) and anterior cingulate (BA 32), right fusiform gyrus (BA 19), left caudate head, and right
thalamus during motor inhibition tasks (Go-NoGo or Stop signal tasks) in ADHD [13].
Impulsivity linked with inadequate reward processing that involves decision-making and
reward evaluation activates medial prefrontal cortex, medial orbitofrontal cortex, anterior
cingulate, hippocampus, insula, amygdala, and ventral striatum or nucleus accumbens [9,
14]. Subjects with ADHD show decreased activation within this network, with a replicated
finding of hypoactivation of ventral striatum during reward anticipation [15]. Edel et al. [16]
showed that there might be dissociation of the neuronal deficit during reward processing
between ADHD subtypes: predominantly inattentive subtype was linked with hypoactivation
of ventral striatum, combined subtype with hypoactivation of orbitofrontal cortex.
1.2.2. Attention deficit
Deficits of sustained attention belong to very common findings in ADHD. A meta-analysis of
fMRI studies (that used Continuous performance, Odd-ball, or Mental rotation tasks) detected
significant decrease of brain activity in the right dorsolateral prefrontal cortex (BA 8, 46), right
inferior parietal cortex (BA 40), right precuneus (BA 7), right superior temporal gyrus (BA 42),
left putamen, and right thalamus; on the other hand, increased activity in cerebellum was
found too [13]. However, individual studies show also involvement of the left hemisphere
dysfunctions – using fMRI during vigilance task in boys with ADHD found decreased
activation of the left dorsolateral prefrontal cortex (middle frontal gyrus, BA 46, 9, 8), superior
parietal cortex (postcentral gyrus, BA 6, 4, 2, 1, 7), and subcortical structures involved in fronto-
striatal loops [17]. DLPFC activation was related to the test performance, i.e. the reduced
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DLPFC activation corresponded to deficits in sustained attention. Findings of abnormal
functional connectivity within fronto-striatal loop during Continuous performance task in
children with ADHD [18] demonstrates that the abnormal pattern of activity affects whole
networks – which might be advantageous for the TMS applications, where only selected parts
of the network are accessible, and still the influence of a part of a network may affect inter-
connected areas as well.
Arnsten describes a comprehensible model of attention, with two systems. The “bottom-up”
system represents stimuli from the environment processed in association areas (posterior parts
of the brain – the occipital, parietal, and temporal lobes) and projected to the PFC according
to their salience. The “top-down” system represents the actions of the PFC which chooses
which stimuli will be enhanced (relevant) and which will be suppressed (distracting) according
to their relevance for long-time goals processed by the PFC. The PFC uses its extensive
projections back to the sensory association cortices. [19]
In addition to the disorders of attention, dysfunction of several other cognitive functions, such
as working memory and executive functions can be found in ADHD [20], albeit only in a
subgroup of patients [21]. They are linked to reduced DLPFC activity [22].
1.2.3. Time processing
There exists growing evidence on impairment of various time-processing mechanisms in
ADHD that form an independent domain of ADHD manifestation: perceptual timing,
temporal foresight, and motor timing reflected in abnormalities of interval duration estimation
and discrimination, delay discounting, and sensorimotor synchronization [23], i.e. processing
of both interval estimation and fine-grained millisecond timing of brain events is affected.
Since there is a relationship between time-processing deficits and measures of impulsivity and
attention deficit [23], it seems that this neurocognitive abnormality may be another source of
core behavioral manifestations of ADHD.
Functional neuroanatomy of time-processing deficits in ADHD converges on the pattern of
reduced activation of bilateral inferior frontal gyrus, orbitofrontal cortex (in particular, in time
foresight paradigms – delayed discounting task), SMA, precentral gyrus, insula, and cerebel‐
lum [24–27].
1.2.4. Emotion dysregulation
Emotion dysregulation is an important component of ADHD and according to many it should
be considered in diagnostic conceptualizations of ADHD [28, 29]. It was found to be linked to
some ADHD variables such as greater ADHD functional impairment, lower quality of life,
ADHD persistence, and higher ADHD severity in childhood [30]. Shaw et al. [31] describes
emotion dysregulation as emotional expressions and experiences that are excessive in relation
to social norms and context-inappropriate; rapid, poorly controlled shifts in emotion (“labili‐
ty“); and the anomalous allocation of attention to emotional stimuli. In the study of Vidal et
al., adults with ADHD presented higher levels of emotional lability when compared to clinical
control subjects and community subjects [30].
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Similarly to attention, there are different systems that regulate emotions. The "bottom-up"
system is represented by emotional responses of the amygdala and ventral striatum to external
stimuli. Their projections to prefrontal cortex (PFC) draw attention to emotionally loaded
processes and similarly to attention, this bottom-up system stresses salience of emotions and
not their current relevance. Subcortical structures, the amygdala, and the ventral striatum play
a key role in generation of emotions. These areas project to ventrolateral prefrontal cortex
(VLPFC), which is not a centre for emotion regulation, rather it decides if regulation is
necessary. The need for regulation is signalized to the dorsolateral PFC (DLPFC), either via
the anterior middle cingulate cortex or directly. The DLPFC processes the information from
VLPFC and relays it to other brain structures involved in emotomotor control [32], which
represents the “top-down” regulation based on relevance of the emotion for tasks and goals
currently processed by the DLPFC. This ability is included in the broader concept of "executive
functions", i.e. the processes that are focused on attaining long-term goals through organizing
and planning.
Emotion dysregulation in ADHD may arise from deficits at multiple levels. These range from
abnormal early orienting to emotional stimuli, particularly with regard to negative stimuli and
reward valuation through an inability to recruit top-down regulatory effort in response to
emotional stimuli. Meantime, deficits in cognitive processes, including working memory and
response inhibition, may contribute to emotion dysregulation, but they do not seem to be alone
to explain its presence in ADHD [31]. In children with ADHD and emotional lability, deficits
in emotion regulation were associated with altered amygdala–cortical intrinsic functional
connectivity (iFC). The cortical structures involved were rostral anterior cingulate cortex
(positive iFC in individuals with high emotional lability). Emotional lability scores were also
negatively associated with iFC between bilateral amygdala and posterior insula/superior
temporal gyrus [33].
1.2.5. Motor symptoms and hyperactivity
Hyperactivity is a non-specifically increased tendency to act. The question is if it is a conse‐
quence of inadequate motor inhibition or if there are other sources for hyperactivity. Although
there are no functional imaging studies of hyperactivity per se, there are reports of motor
system changes in ADHD. During simple motor tasks, reduced activity of primary motor (BA4)
and sensor cortex in ADHD subjects was observed [34]. Moreover, abnormal co-operation of
motor system was seen as well – McLeod et al. (2014) [35] described reductions in functional
connectivity at rest between the primary motor cortex and the bilateral inferior frontal gyri,
right supramarginal gyrus, angular gyri, insular cortices, amygdala, putamen, and pallidum.
It seems that increased lateral prefrontal cortex activity is involved in compensation of
inadequate motor system performance in ADHD subjects [36].
1.3. Potential targets for rTMS treatment
From the network point of view, there seems to be an involvement of at least three distinct
circuits – lateral attentional network, medial reward-related network, and fronto-cerebellar
time-processing network. At present, the state-of-the-art rTMS technology enables modulation
ADHD - New Directions in Diagnosis and Treatment336
of regions that lay close to the surface of the brain, i.e. lateral parts. Based on the above reviewed
functional neuroanatomy, potential accessible candidate targets are represented by dorsolat‐
eral prefrontal cortex, ventrolateral prefrontal cortex, inferior frontal gyrus, dorsal parts of
supplementary motor cortex, and cerebellum. Modulation of dorsolateral prefrontal cortex
may lead to changes of attention, working memory, and executive functions, but through the
top-down regulations it may exert effects on emotional dysregulation symptoms, and impul‐
sivity. Inferior frontal gyrus stimulation may lead to changes in behavioral inhibition and time
estimation. Cerebellar stimulation may influence time processing, cognitive functioning, and,
perhaps, even the affective symptoms of ADHD. rTMS of cerebellum is technically possible;
however, the tolerability due to the neck muscle stimulation might limit its clinical use. Quite
recently, rTMS approaches that use a double-cone or HAUT coils demonstrated their ability
to modulate activity of medial cortical regions [37, 38]. This technological advancement would
enable direct targeting of medial cortical nodes related to reward processing, which may bring
increased efficacy in the treatment of impulsivity in ADHD.
2. Repetitive transcranial magnetic stimulation
2.1. General description and current use in psychiatry
Transcranial magnetic stimulation (TMS) is a diagnostic and therapeutical technique based on
the principle of electromagnetic induction of electric current in the brain. It uses high-density
magnetic field (approximately 2T lasting 0.1 ms) to induce electric field inside cortex, which
is able to depolarize neurons [39]. Repetitive transcranial magnetic stimulation (rTMS)
depolarizes neurons repetitively with either high (HF) or low frequency (LF) in order to change
neuronal excitability for a longer period of time. The excitability can be lowered by using a
low-frequency stimulation [40], and vice versa, high-frequency stimulation is able to render
the neuron more sensible to stimuli, thus more excitable [41]. Findings from the neuroimaging
studies that have localized dysfunctional parts of cortex in particular diseases can be trans‐
formed into new treatment approaches. However, recent findings suggest that the effect of
rTMS is more complex and the excitatory/inhibitory paradigm is not fully satisfying as some
works suggest mixed excitatory and inhibitory effects of either HF or LF-rTMS [42] and the
excitatory effect of HF-rTMS on motor-evoked potentials might be caused by the decrease of
gamma-amminobutyric acid-mediated inhibition [43]. The method is non-invasive and few
side effects have been reported so far. The complete mechanism of changes remains unclear,
but it is believed that rTMS affects gene expression [44], synaptic plasticity, dopamine release
[45, 46], and release of endogenous opioids [47]. The ability of rTMS to affect not only the
particular area it is aimed at but also the whole functional site is crucial as it is able to modulate
function in more distant parts of brain [48, 49].
Each rTMS protocol is characterized by its focus of stimulation, frequency of stimuli, intensity,
frequency of sessions, total number of pulses, train and intertrain time, a total time of session,
and the shape of the coil. Taking this into account, many variables which can modify the effect
of stimulation are present and researchers need to consider each of them when designing a
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protocol. The choice of the region of the brain cortex used for stimulation is based on lesion
studies or imaging data that suggest an approximate localization of the studied cortical
function, e.g. dorsolateral prefrontal cortex, supplementary motor area, etc. The choice of a
particular place on subject’s scalp to put on the coil is based on anatomy or imaging data of
the particular subject. The intensity of each stimulation is usually standardized according to
a percent of RMT (resting motor threshold), determined in each individual. 1 Hz stimulation
is typically used for LF-rTMS, and 5–20 Hz stimulation in HF-rTMS. Multiple imaging
techniques are used for online monitoring of rTMS effect in studies (EEG, PET, fMRI).
Another form of rTMS – the Theta-Burst stimulation (TBS) – consists of 3 pulses at 50 Hz
repeated at 200 ms interval (hence 5 Hz frequency). This stimulation, when applied continu‐
ously (cTBS), is considered to mimic long-term depression effect on cortical excitability, while
when applied intermittently (iTBS), long-term potentiation-like (LTP-like) effect is observed
[50]. However, Gamboa showed that doubling the duration of the stimulation leads to
conversion of its effect [51].
Largest body of evidence supporting the efficacy of rTMS was reached in trials with patients
suffering of drug-resistant major depression and this success of rTMS led to approval of this
technique in this indication by Food and Drug Administration in the USA in 2008. The method
is also used in neuropsychiatry for the treatment of anxiety disorders [52], child autism [53,
54], Parkinson’s disease [55], and positive symptoms of schizophrenia such as auditory
hallucinations [56, 57]. And for number of other diseases, this technique is in various states of
research (neuropathic pain, Tourette’s syndrome, stroke, amyotrophic lateral sclerosis,
multiple sclerosis, epilepsy, Alzheimer’s disease, tinnitus, obsessive compulsive disorder,
negative symptoms of schizophrenia, substance abuse, addiction, and craving) [55].
2.1.1. Safety issues
Although rTMS is believed to be a very safe technique, several side effects were described in
previous studies. Of the major concern is the possibility of seizure induction, mostly during
excitatory rTMS (HF), considered the most serious TMS-related acute side effect. However,
the incidence of seizures was extremely rare (0.1–0.5%) and was mostly connected to receiving
rTMS exceeding previous guideline recommendations, often in patients under a medication
potentially lowering the seizure threshold. A short intertrain time is considered to be one of
the potential triggers of seizures during rTMS [58]. Further research and analysis should be
performed to identify protocol aspects and indication criteria lowering the risk of seizures.
As rTMS produces rather intensive noise (over 120 dB) [59], considerations about its effect on
patient's hearing should be taken into account. The amplitude of rTMS sound depends on the
coil design and the absolute stimulation intensity. Thus, sound intensity experienced by the
patient during stimulation depends directly on the subject’s motor threshold which is indi‐
vidually variable across the population [60]. According to safety guidelines [58], hearing
protection is highly recommended as some subjects with no hearing protection experienced a
hearing loss or threshold shifts in past studies [61, 62].
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Headache is a relatively frequent adverse effect of rTMS, but this discomfort usually vanishes
within minutes with either no need for medications or it responds to common analgesics. A
scalp pain or discomfort is a common adverse effect of rTMS as well and an ideal method to
decrease this discomfort is still in research (e.g. local application of lidocaine) [63, 64]. How‐
ever, the scalp pain and discomfort typically vanish straight after the application of pulses and
eventually it seems there is a kind of accommodation as the first session is usually refered as
the most painful.
Repetitive transcranial magnetic stimulation is contraindicated in patients with metallic
(conductive, ferromagnetic, or other magnetic-sensitive) objects in or near the head (within 30
cm of the treatment coil), e.g. implanted electrodes, bullet fragments, aneurysm clips, stents
and similar, or implanted stimulator devices in or near the head, e.g. deep brain stimulators
and vagus nerve stimulators.
2.2. Repetitive transcranial magnetic stimulation in the treatment of ADHD
2.2.1. Children and adolescents
Several limitations exist for the use of any therapy in children regarding their developing brain.
Every novel therapy in neuropsychiatry needs to be evaluated carefully in children, especially
in the terms of long-term safety. According to the theory of “sensitive periods“ (a time period
within brain development when an intervention has a strong effect on the brain [65]) in
childhood, neuromodulation methods might be able to affect the brain function in a more stable
and effective way during these periods. Although there is no evidence of any serious side
effects of rTMS in children, it has to be kept in mind that the risk of inducing maladaptive
neuroplasticity during sensitive periods of development of the child brain is still present and
there is great need to clearly describe the neurophysiology of the impact of rTMS on a
developing brain [54].
Dorsolateral prefrontal cortex (DLPFC), and especially right DLPFC, is believed to be highly
involved in the pathophysiology of ADHD – see above. Two studies reported an application
of rTMS over DLPFC in children and adolescents with ADHD. Weaver and colleagues (2012)
applied HF-rTMS (10 Hz, 100% of the observed motor threshold) over the right DLPFC in 9
young patients (4 of them between 15 and 17). Their sham-controlled crossover safety study
revealed an overall improvement in ADHD symptoms, but no difference between the sham
and the active rTMS sessions [66]. Isenberg et al. showed that LF-rTMS on the left DLPFC has
similar effect in patients with depression as HF-rTMS on the right DLPFC [67]. Gomez et al.
based their protocol on these findings and applied 1 Hz rTMS of 90% of the rest motor threshold
over the left DLPFC in ten school-aged boys (ages 7–12) suffering from ADHD. Although this
study was performed to establish tolerability and safety of this protocol in children, their
preliminary results have been promising because of significant clinical improvement of ADHD
symptoms (mainly inattentiveness in school and hyperactivity/impulsivity at home) as
referred by teachers, parents, and partly confirmed by the attending physician [68].
Two other studies applied the rTMS in children with ADHD for different purposes. One of
them successfully evaluated TMS-evoked N100 measuring by EEG as a suitable marker for
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online monitoring of rTMS effects in children with ADHD as they found significant reduction
of the amplitude of TMS-evoked N100 in comparison to the sham stimulation [69]. Loo et al.
(2006) used 10 Hz rTMS on two 16-years-old girls suffering from depression and ADHD and
described improvement in depression but no change in ADHD symptoms [70]. Nevertheless,
all these studies revealed no serious adverse effects in children with ADHD undergoing rTMS.
Considering the wide comorbidity of ADHD and Tourette‘s syndrome (60–80% according to
hospital studies) [71], it is worth noticing some promising results of rTMS treatment. Two
studies [72, 73] applied LF-rTMS of 100/110% of motor threshold over the supplementary
motor area and showed significant improvement in tics; these improvements lasted for a
minimum of 6 months [73]. However, three participants with ADHD reported no change in
ADHD symptoms. Nevertheless, improving the tic symptoms can increase the compliance of
ADHD patients and give the therapist possibility to better address the therapy of ADHD
symptoms.
2.2.2. Adults
As the recent findings have revealed, in over 50% of children with ADHD the symptoms persist
to adulthood. Adult ADHD has become a large point of interest for research. Considering the
fact that attention deficit symptoms tend to persist into adulthood more often than hyperac‐
tivity symptoms, a pilot study was performed using HF-rTMS on the right DLPFC. This
stimulation resulted in improvements in attention but with small clinical significance [74]. One
patient in a case study reported particular dysphoria, inability to respond emotionally,
hypobulia, tension, and impaired attention after the same stimulation protocol [75]. Applying
inhibitory protocol on the contralateral DLPFC might be worth trying as well.
On the other hand, two studies with inhibitory protocol with LF-rTMS over the supplementary
motor area (SMA) reported significant clinical improvement in hyperactivity in two women
with the hyperactive/impulsive subtype of ADHD [76, 77].
Some studies focused on other functions typically impaired in ADHD (e.g. attention, impul‐
sivity) trying to influence them by non-invasive brain stimulation in healthy population. The
DLPFC was stimulated in studies measuring the effect of stimulation on sustained attention
or impulsivity or inhibition. HF-rTMS over the left DLPFC led to better performance in the
Conners Continuous Performance task [78]. Continuous Theta-burst stimulation over the
DLPFC resulted in choosing larger delayed rewards rather than smaller immediate ones in the
Delay Discounting test [79]. Similar results were reached after stimulation of the medial
prefrontal cortex by HF-rTMS [80]. Interestingly, anodal transcranial direct current stimulation
(tDCS) applied over either the left or the right DLPFC resulted in more careful driving on a
driving simulator [81].
The performance in the Stop Signal task, which is also used for the diagnosis of impulsivity,
was affected by anodal tDCS over the pre-SMA and participants performed greater number
of correctly inhibited responses in comparison with the active stimulation over M1 [82].
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2.3. Why are the results of studies so variable?
The differences between individual studies result from their methodology. There are great
many parameters in rTMS that can be adjusted differently. The parameters are described above
and studies use unequal designs. The reason for such differences is the practical absence of
standard rTMS protocols for ADHD, the firm knowledge of the right technical setting is absent.
There is a possibility to use parameters that have been successful in the treatment of depressive
disorder or negative symptoms of schizophrenia where the stimulation of the DLPFC is
applied as well – high frequency, ideally 10Hz, above-threshold intensity (above 100% of the
individual’s resting motor threshold), higher number of treatment sessions (15 at least), higher
number of pulses per session and totally during the treatment, and possibly the use of
structural and functional brain imaging techniques for more accurate targeting of the best place
of stimulation. This protocol has to be tested in trials (double-blind and placebo-controlled
ideally) that could prove whether these parameters are really optimal for patients with ADHD.
It is worth noting that in patients with obsessive-compulsive disorder this assumption was
wrong and there is a search for a different target instead of the DLPFC. Even the protocols for
much more studied disorders like depression or negative symptoms of schizophrenia differ,
however, in different studies. In ADHD studies, the inter-individual variability is an important
factor as extensive studies are lacking. The same protocol may lead to different outcomes in
individual patients and in small sample studies the inter-individual variability can overweight
the inter-group variability.
The measures of outcome can also differ in different studies. ADHD is defined by its diagnostic
criteria and a lot of questionnaires are used to measure the changes in symptomatology. The
functioning in individuals with ADHD varies considerably and the results in neuropsycho‐
logical tests correspond to this variability. Changes induced by rTMS may be small and only
detectable in testing, but patients’ expectations may be higher with such a “hi-tech treatment”
so patients can subjectively overestimate or underestimate the results. More studies examining
patients’ subjective feelings as well as objective measures of attention and hyperactivity before
and after rTMS are needed.
3. Case study
An adult female patient 25-years-old with ADHD, a university student, was enrolled to the
pilot study which examined the efficacy and safety of repetitive transcranial magnetic
stimulation (rTMS) in adult ADHD. Although she described having had the symptoms of
ADHD before starting school education at the age of 6 years, she was never diagnosed by a
psychiatrist and was never treated. She was assessed by only a school psychologist who
communicated to her parents that she would not be able to study at university. She, however,
did not give up, and this motivated her to work harder. She had good results at basic and
secondary schools even though she suffered from inattention. The results at university were
considerably poorer, but with a high level of motivation she was able to finish her bachelor’s
degree. Nonetheless, she had to consult a psychiatrist for the first time during the studies and
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she was diagnosed with adjustment disorder with prevailing depressive mood and suspected
ADHD. She was medicated with paroxetine 20 mg daily and also with valproate 500 mg daily
for emotional instability. Her mood improved with the medication, but she still had disturbing
symptoms of inattention. A year later she found our experimental rTMS study and agreed
willingly to participate.
Before the procedure, she was assessed by two psychiatrists experienced in diagnosing ADHD
and the diagnosis was confirmed. Consecutively, she had a neuropsychological evaluation
aimed at attention. She did not meet any contraindication for rTMS (epilepsy, pathological
EEG, metal object in skull, cardiostimulator, or drug pump) and thus she could start rTMS.
The high-frequency stimulation of the left dorsolateral prefrontal cortex (DLPFC) was used;
this alternative had been previously used in another patient with ADHD (see [74]) and seemed
effective and well-tolerated.
Before the initiation of stimulation, we first localized the spot whose stimulation triggered a
motor-evoked potential (MEP) in the abductor pollicis brevis muscle. Then, we determined in
a standard way the resting motor threshold (RMT) as the lowest stimulation intensity that is
able to trigger a MEP of at least 50 µV in the above mentioned muscle five times out of ten
consecutive trials [83]. The exact stimulation localization was determined according to the “5
cms rule“ – that is, a localization 5 cm more rostral from the RTM spot. The patient had ten
sessions during her treatment with high-frequency (10Hz) rTMS; the intensity was 110% of
the RTM; and the pulse count was 1500 in a session with the stimulation train invariably 10
seconds long with an inter-train pause of 30 seconds. The treatment was well tolerated and no
adverse effects were seen during the whole course of treatment. After treatment, she did not
feel any subjective improvement in attention, but the control neuropsychological evaluation
showed improvements in almost all tests focused on attention. A few weeks after rTMS, she
was informed she was in the second trimester of pregnancy which meant she had been
pregnant in the course of the rTMS treatment. In a year, she contacted us again and reported
her pregnancy without complications as well as the delivery of a healthy child. She even
managed to finish successfully her university studies.
This case study supports with evidence the hypothesis that rTMS may be an effective and safe
treatment option for adult ADHD. It seems safe even in pregnant female subjects; the evidence
is however insufficient.
4. Summary
rTMS treatment of ADHD is in its infancy. The best treatment regimen, duration of acute
treatment, neurostimulation target, and symptoms modulated by rTMS are to be determined.
Although the method proved to be effective in several psychiatric indications (schizophrenia,
major depression), the efficacy in ADHD needs to be studied in detail before any final
conclusions. The neurobiology of ADHD is linked with dysfunctions of cortical regions that
are accessible to rTMS modulation. The many regulatory functions of DLPFC enable TMS
stimulation trials for many disorders. Majority of neurobiologic findings in ADHD involve
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this cortical area, thus giving sense to the use of rTMS in ADHD. Since frequent limitation of
rTMS studies is only approximate localization of stimulation targets, when trying to target
specific regions linked with ADHD, fMRI-guided neuronavigation may be of crucial impor‐
tance for the success of treatment regimens.
5. Abbreviations
This chapter tries to provide with current knowledge about the neurobiology of ADHD for the
purpose of explaining the role of a novel treatment approach in psychiatry – repetitive
transcranial magnetic stimulation. The structures of brain have usually long and complicated
names. We use some abbreviations to shorten the text. All abbreviations are written in full
words as they occur for the first time. Here are some of the most common for your reference.
ADHD – attention-deficit hyperactivity disorder
BA – Brodmann area
DCS – direct current stimulation
DLPFC – dorsolateral prefrontal cortex
fMRI – functional magnetic resonance imaging
HF – high frequency
LF – low frequency
PFC – prefrontal cortex
SMA – supplementary motor area
rTMS – repetitive transcranial magnetic stimulation
TMS – transcranial magnetic stimulation
VLPFC – ventrolateral prefrontal cortex
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